Advertisement Global Health Ventures Completes X-Excite Prototype - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Global Health Ventures Completes X-Excite Prototype

Global Health Ventures has successfully completed the prototype preparation of its sublingual X-Excite pill. With the combined efforts of its contract manufacturers, Pharmex Rom Industries and Globe Labs, the company has been able to resolve the final hurdle being the hardness of the pill and the length of time it took for the pill to disintegrate under the tongue.

The company said that they have the final color and taste of the tablet, and managed to meet their end goal of having a tablet that dissolves in less than 60 seconds under the tongue.

Hassan Salari, president and CEO of Global Health Ventures, said: “We are very pleased that the final hurdle in manufacturing the X-Excite pill is behind us. We will now aggressively move forward to the full manufacturing stage for initiating our human clinical trials. 2010 should be a very exciting year for us as we move our products from concept through human trials and closer to commercialization.”